Patent directory · USPTO A61K / A61P
Browse patents
Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.
Quick answer
NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.
Patent results
-
US 10596216
Use of a Withania extract for the treatment of amyloid-related diseases
granted -
US 10596158
Solid forms of {[5-(3-chlorophenyl)-3-hydroxypyridine-2-carbonyl]amino}acetic acid, compositions, and uses thereof
granted -
US 10596185
Flavonoid compositions and uses thereof
granted -
US 10596125
Nanowire-coated microdevice and method of making and using the same
granted -
US 10596260
Reoviruses having modified sequences
granted -
US 10588895
Quinuclidine derivatives and medicinal compositions containing the same
granted -
US 10592168
Injectable flowable composition comprising buprenorphine
granted -
US 10591471
Suppression of SPLA2-integrin binding for treating an inflammatory condition or suppressing cell proliferation
granted -
US 10590416
RNAi agents for inhibiting expression of alpha-ENaC and methods of use
granted -
US 10588874
Toxic aldehyde related diseases and treatment
granted -
US 10590182
Binding-triggered transcriptional switches and methods of use thereof
granted -
US 10590171
Exosomes and methods of making and using the same
granted -
US 10590155
Mitochondria-targeting fluorescent potassium+ sensor and method of making the same
granted -
US 10590414
Brush polymer-assisted compaction of oligonucleotides
granted -
US 10590121
Kinase inhibitors and methods for making and using
granted -
US 10590107
Diamide compounds having muscarinic receptor antagonist and Beta2 adrenergic receptor agonist activity
granted -
US 10590142
Deuterated amlexanox
granted -
US 10590114
Compounds, compositions, and methods
granted -
US 10590090
2,5-disubstituted 3-methyl pyrazines and 2,5,6-trisubstituted 3-methyl pyrazines as allosteric SHP2 inhibitors
granted -
US 10590082
N-(5-((aryl or heteroaryl)methyloxy)pentyl)-substituted iminosugars as inhibitors of glucosylceramide synthase
granted -
US 10589997
Discrete carbon nanotubes with targeted oxidation levels and stable gel formulations thereof
granted -
US 10589250
Automated purification and formulation device for radiopharmaceutical compounds
granted -
US 10589003
Methods for coating surfaces with antimicrobial agents
granted -
US 10590074
Potent and selective inhibitors of monoamine transporters; method of making; and use thereof
granted
Frequently asked questions
What patents are included in this directory?
We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.
How do I search for a patent?
Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.
How is this different from the patent intelligence dashboard?
The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.